Cover Image

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib

Saved in:

Bibliographic Details
Main Authors:	David Nash, BHSc (Author), Mark G. Kirchhof, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Upadacitinib - New Janus Kinase Inhibitor - Literature Review
by: Michalina Grzelka, et al.
Published: (2024)

Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
by: Nicolas Caudrelier, MD, et al.
Published: (2023)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
by: Miguel Nogueira, et al.
Published: (2021)

Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib
by: Jannett Nguyen, MD, et al.
Published: (2021)

Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
by: Efrat Bar-Ilan, MD, et al.
Published: (2022)

Brunsting-Perry pemphigoid transitioning from previous bullous pemphigoid
by: Shengru Zhou, MD, PhD, et al.
Published: (2020)

Pterygium in bullous pemphigoid: An unusual complication
by: Eckart Haneke, MD, PhD, et al.
Published: (2020)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)

Immunoglobulin M bullous pemphigoid: An enigma
by: Rosalie Baardman, MD, et al.
Published: (2020)

Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review
by: Fangying Su, et al.
Published: (2024)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020)

A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor
by: Yuta Koike, MD, PhD, et al.
Published: (2017)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012)

Bullous pemphigoid successfully treated with dupilumab
by: Daniela de Abreu e Silva Martinez, et al.
Published: (2024)

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis
by: Elizabeth J. Klein, MD, et al.
Published: (2024)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
by: Fabienne Ballanger, et al.
Published: (2023)

Bullous eczema presenting as bullous pemphigoid-like eruption: A case series
by: George Atteh, BS, et al.
Published: (2021)

Janus Kinase inhibitors in dermatology: a review
by: Bárbara Vieira-Granja, et al.
Published: (2023)

Janus Associated Kinases Inhibitors in the Pharmacological Thera
by: Daniela Santos1, et al.
Published: (2017)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024)

Two cases of bullous pemphigoid effectively treated with oral tofacitinib
by: Soundos Youssef, MD, et al.
Published: (2023)

Bullous pemphigoid
by: Denise Miyamoto, et al.

Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib
by: Albert E. Zhou, MD, PhD, et al.
Published: (2024)

Janus kinase inhibitors: between prescription authorization and reimbursability
by: F.R. Spinelli, et al.
Published: (2023)

Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018)

Janus kinase inhibitors - their current applications and future prospects
by: Natalia Wierzbowska, et al.
Published: (2022)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

Nonbullous pemphigoid mimicking arthropod bite reactions in a patient with previously controlled classic bullous pemphigoid
by: Sierra Parkinson, BA, et al.
Published: (2024)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020)

Semaglutide-associated bullous pemphigoid
by: Clayton P. Burruss, BS, et al.
Published: (2021)

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
by: Singer J, et al.
Published: (2016)

A case of bullous pemphigoid provoked by doxycycline-induced phototoxicity
by: Isabella I. Sanchez, PhD, et al.
Published: (2023)

Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab
by: Yuka Maya, MD, et al.
Published: (2020)

Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection
by: Wesley T. Hodges, MD, et al.
Published: (2024)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
by: Andjela Egger, BS, et al.
Published: (2020)

Cutaneous dermatophytosis mimicking bullous pemphigoid or typical bullous pemphigoid and tinea incognito?
by: Tirado-Sánchez Andrés, et al.
Published: (2019)